APA (7th ed.) Citation

Cai, H., Fang, L., Lin, J., & Zheng, Z. Atezolizumab plus bevacizumab and chemotherapy versus bevacizumab plus chemotherapy for metastatic cervical cancer: A cost-effectiveness analysis. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Cai, Hongfu, Ling Fang, Jingwen Lin, and Zhiwei Zheng. Atezolizumab Plus Bevacizumab and Chemotherapy Versus Bevacizumab Plus Chemotherapy for Metastatic Cervical Cancer: A Cost-effectiveness Analysis. Frontiers Media S.A.

MLA (9th ed.) Citation

Cai, Hongfu, et al. Atezolizumab Plus Bevacizumab and Chemotherapy Versus Bevacizumab Plus Chemotherapy for Metastatic Cervical Cancer: A Cost-effectiveness Analysis. Frontiers Media S.A.